Paediatric Endocrine Guidelines
Paediatric Diabetes Guidelines
Guideline | Type | Source | Date of document /last updated | Review date |
BSPED | BSPED | Nov 2021 | Nov 2024 | |
BSPED | BSPED | Nov 2021 | Nov 2024 | |
BSPED | BSPED | Nov 2021 | Nov 2024 | |
Diabetes (type 1 and type 2) in children and young people: diagnosis and management |
Endorsed | NICE | Dec 2020 | May 2023 |
ACDC Endorsed Diabetes Guidelines
Please refer to the ACDC website for Endorsed Guidelines for the most up to date diabetes guidelines listed below.
Guideline | Type | Source |
Executive summary - A Practical Approach to the Management of Type 2 Diabetes in children and young people under 18yrs | Endorsed | ACDC/BSPED |
Care of the Well Child-Newly Diagnosed with Type 1 Diabetes | Endorsed | ACDC/BSPED |
Sick day guideline executive summary v4 | Endorsed | ACDC/BSPED |
Sick day guideline Main V4 | Endorsed | ACDC/BSPED |
Management of Hypoglycaemia in Children and Young People with Type 1 Diabetes | Endorsed | ACDC/BSPED |
A Practical Approach to the Self Management of Diabetes As An Inpatient for Children and Young People Under 18 years | Endorsed | ACDC/BSPED |
A Practical Approach to the Management of Continuous Glucose Monitoring (CGM) / Real-Time Flash Glucose Scanning (FGS) in Type 1 Diabetes Mellitus in Children and Young People Under 18 years | Endorsed | ACDC/BSPED |
A Practical Approach to the Management of Steroid, Chemotherapy or Transplant Induced Hyperglycaemia or Diabetes in Children and Young People Under 18 years in the Acute or Inpatient Setting | Endorsed | ACDC/BSPED |
Dexcom G4 CGM Training Leaflet for Healthcare Professionals and Patients | Endorsed | ACDC/BSPED |
Dexcom G5 CGM Training Leaflet for Healthcare Professionals and Patients | Endorsed | ACDC/BSPED |
Dexcom G6 CGM Training Leaflet for Healthcare Professionals and Patients | Endorsed | ACDC/BSPED |
Medtronic 640G Training Leaflet for Healthcare Professionals and Patients | Endorsed | ACDC/BSPED |
Libre FGS Training Leaflet for Healthcare Professionals and Patients | Endorsed | ACDC/BSPED |
Care of children under 18 years with Diabetes Mellitus undergoing Surgery - currently being updated | Endorsed | ACDC/BSPED |
Executive Summary: A Practical Approach to the Management of Continuous Glucose Monitoring (CGM) / Real-Time Flash Glucose Scanning (FGS) in Type 1 Diabetes Mellitus in Children and Young People Under 18 years | Endorsed | ACDC/BSPED |
Practical Management of Hyperglycaemic Hyperosmolar State (HHS) in children | Endorsed | ACDC/BSPED |
Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) | Endorsed | ACDC/BSPED |
Executive Summary- Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) | Endorsed | ACDC/BSPED |
Patient Advice for Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) | Endorsed | ACDC/BSPED |
*BSPED DKA Guidelines: The Clinical Committee of BSPED are aware that NICE has published its revised guidance on the management of Type 1 and Type 2 Diabetes in Children and Young People(CG 18) We are also aware that this revised NICE guidance differs from the current interim BSPED guidance on the cloud the fluid management of DKA. The Clinical Committee plan to review this situation very quickly but do not feel that the current BSPED DKA guidance need to be removed from the website while this review and revision takes place.
Local/ Other Endocrine Guidelines
These guidelines are local/other endocrine guidelines which have been made available to BSPED members. The BSPED have not been involved in the development of these guidelines and take no responsibility for the content. Please note local guidelines may vary between Trusts.
If a local trust wishes to publish their guidelines on the BSPED website, please email the BSPED Office (bsped@endocrinology.org) and we will put you in touch with our Clinical Guideline Officer, Dr Jarod Wong.
Category | Guideline | Type | Source | Date of document |
Adrenal |
The Investigation of suspected Paediatric Cushing’s Syndrome |
Supported | Barts and the London School of Medicine | April 2021 |
Growth |
Recombinant IGF-1 Therapy in Children with Severe Primary IGF-1 Deficiency |
Supported | Barts and the London School of Medicine | April 2021 |
Puberty/Gonads | Supported | QMUL/Barts/UCLH/Alder Hey | April 2022 |
Useful Resources
Category | Guideline | Source | Date |
Thyroid | Paediatric Graves Disease Guildeline 2022 | British Thyroid Association Guideline management of Paediatric Graves disease | 2022 |
Hyperinsulinism |
UK national consensus |
2023 |
Chaperone documentation for clinical notes (provided by Birmingham Children's Hospital):